Intracameral triamcinolone helps to visualize and remove the vitreous body in anterior chamber in cataract surgery

Am J Ophthalmol. 2004 Oct;138(4):650-2. doi: 10.1016/j.ajo.2004.05.033.


Aim: To study the effects of intracameral injection of triamcinolone acetonide on visualizing and removing the vitreous body from the anterior chamber in cataract surgery.

Design: Observational case series.

Methods: Six eyes of six patients had the posterior capsule ruptured and the vitreous body prolapsed or incarcerated into the anterior chamber during cataract surgery. To visualize vitreous body, triamcinolone acetonide solution was injected into the anterior chamber and the vitreous body was resected. The intraoperative findings, results, and complications were evaluated.

Results: Vitreous body was well observed under surgical microscopy and was resected safely and completely. Minimum inflammation was observed postoperatively, and the patients obtained good visual acuity. No serious complications were found. One eye showed increased intraocular pressure (40 mm Hg), which was normalized by additional washing of the anterior chamber.

Conclusions: Appropriate use of intracameral triamcinolone acetonide is beneficial to visualize and remove the vitreous body from the anterior chamber during cataract surgery, and sufficient washing of the anterior chamber is necessary to avoid complications.

MeSH terms

  • Aged
  • Anterior Chamber / pathology*
  • Eye Diseases / diagnosis*
  • Eye Diseases / etiology
  • Female
  • Glucocorticoids*
  • Humans
  • Injections
  • Intraoperative Complications / diagnosis*
  • Lens Capsule, Crystalline / injuries
  • Lens Implantation, Intraocular
  • Male
  • Phacoemulsification*
  • Prolapse
  • Rupture
  • Triamcinolone Acetonide*
  • Visual Acuity
  • Vitreous Body / pathology*


  • Glucocorticoids
  • Triamcinolone Acetonide